Work

KISS1R Antagonism as a Promising Anti-Cancer Approach An Overview on Function, Molecular Mechanisms and Therapeutic Potential

Year: 2024

Type: article

Abstract: Herein, we explore the Kisspeptin 1 Receptor KISS1R as a potential therapeutic target for the restoration of drug sensitivity in Triple Negative Breast Cancer TNBC clinical settings.

Source: Journal on oncology

DOI: 10.52768/2692-563x/1147

Author: James J Scanlon

Institutions: Kingston University London, University of Surrey

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W4405996478

FWCI:

Cites:

Cited by:

Related to: 10